#BEGIN_DRUGCARD DB02313

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C31H41FN4O7

# Chemical_IUPAC_Name:
ethyl (4S)-4-[(2R,5S)-2-[(4-fluorophenyl)methyl]-6-methyl-5-[(5-methyl-1,2-oxazol-3-yl)formamido]-4-oxoheptanamido]-5-[(3S)-2-oxopyrrolidin-3-yl]pentanoate

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
4-{2-(4-Fluoro-Benzyl)-6-Methyl-5-[(5-Methyl-Isoxazole-3-Carbonyl)-Amino]-4-Oxo-Heptanoylamino}-5-(2-Oxo-Pyrrolidin-3-Yl)-Pentanoic Acid Ethyl Ester

# HET_ID:
AG7

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C31H41FN4O7/c1-5-42-27(38)11-10-24(16-21-12-13-33-29(21)39)34-30(40)22(15-20-6-8-23(32)9-7-20)17-26(37)28(18(2)3)35-31(41)25-14-19(4)43-36-25/h6-9,14,18,21-22,24,28H,5,10-13,15-17H2,1-4H3,(H,33,39)(H,34,40)(H,35,41)/t21-,22+,24-,28-/m0/s1

# InChI_Key:
InChIKey=LMIUALQNZXJHOG-TYFYUWPDSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2313

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
600.6782

# Molecular_Weight_Mono:
600.295927891

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1CQQ

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
2.59

# Predicted_LogS:
-4.2

# Predicted_Water_Solubility:
4.00e-02 g/l

# Primary_Accession_No:
DB02313

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936345

# PubChem_Substance_ID:
46505563

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00453

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CCOC(=O)CC[C@@H](C[C@@H]1CCNC1=O)NC(=O)[C@@H](CC(=O)[C@@H](NC(=O)C1=NOC(C)=C1)C(C)C)CC1=CC=C(F)C=C1

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:21:00 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasmic

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
X02316

# Drug_Target_1_GenBank_ID_Protein:
1617204

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
Not Available

# Drug_Target_1_Gene_Sequence:
>6453 bp
ATGGGTGCACAGGTTTCAAGACAAAATGTTGGAACTCACTCCACGCAAAACTCTGTATCA
AATGGGTCTAGTTTAAATTATTTTAACATCAATTATTTCAAAGATGCTGCTTCAAATGGT
GCATCAAAACTGGAATTCACACAAGATCCTAGTAAATTTACTGACCCAGTTAAGGATGTT
TTGGAAAAGGGAATACCAACACTACAGTCCCCCACAGTGGAGGCTTGTGGATACTCTGAT
AGGATTATACAGATTACCAGAGGAGATTCAACCATAACCTCACAAGATGTGGCTAATGCT
ATCGTTGCGTATGGTGTTTGGCCACATTATCTATCCTCCAAGGATGCCTCTGCAATTGAT
AAACCCTCTCAACCAGATACATCTTCTAATAGATTTTATACTCTAAGGAGTGTGACCTGG
AGCAGTTCCTCAAAGGGTTGGTGGTGGAAACTACCTGATGCACTCAAGGACATGGGTATT
TTTGGTGAAAACATGTTTTATCATTACCTGGGTAGGAGTGGATACACAATACATGTGCAG
TGTAATGCTAGTAAATTTCACCAGGGTACACTAATTGTTGCTCTGATACCTGAGCATCAG
ATTGCAAGTGCCTTACATGGCAATGTGAATGTTGGTTACAACTACACACACCCAGGTGAA
ACAGGCAGGGAAGTTAAAGCTGAGACGAGATTGAATCCTGATCTACAACCTACTGAAGAG
TATTGGCTAAACTTTGATGGGACACTCCTTGGAAATATTACCATATTCCCTCATCAATTT
ATCAACTTGAGGAGTAATAATTCTGCCACAATAATTGCCCCTTATGTCAATGCAGTTCCT
ATGGATTCAATGCGGAGCCACAATAATTGGAGTTTGGTAATAATACCAATATGTCCCCTT
GAGACATCAAGTGCAATTAACACAATACCTATTACAATATCTATAAGCCCCATGTGTGCA
GAGTTTTCCGGCGCGCGTGCCAAGCGTCAAGGATTACCAGTTTTCATCACACCAGGTTCA
GGACAGTTTTTGACAACAGATGATTTCCAATCCCCATGTGCACTTCCCTGGTATCACCCA
ACTAAGGAAATTTCTATTCCAGGTGAGGTTAAAAATTTGGTTGAAATTTGTCAAGTAGAC
AGCCTAGTACCAATAAATAACACTGACACCTACATCAATAGTGAAAATATGTATTCTGTT
GTATTGCAATCATCAATTAATGCACCAGATAAGATCTTCTCTATTCGAACAGATGTTGCT
TCCCAACCTTTAGCTACTACTTTGATTGGTGAGATATCTAGCTATTTCACCCACTGGACA
GGGAGTCTCCGTTTCAGCTTCATGTTTTGTGGTACTGCCAACACTACTGTTAAGCTTTTG
TTGGCATACACACCACCTGGTATCGCAGAACCCACCACAAGAAAGGATGCAATGCTAGGC
ACTCATGTTATATGGGATGTGGGGTTGCAGTCTACAATATCAATGGTAGTGCCATGGATT
AGCGCTAGTCATTATAGAAACACATCACCAGGTAGATCTACATCTGGGTACATAACATGC
TGGTATCAGACTAGATTAGTCATTCCACCTCAGACCCCACCAACAGCTAGATTGTTATGT
TTTGTATCTGGGTGCAAAGACTTTTGCTTGCGCATGGCACGAGATACTAACCTACACCTG
CAAAGTGGTGCAATAGCACAGAACCCTGTTGAGAATTATATAGATGAAGTTCTTAATGAA
GTTTTAGTTGTCCCAAATATTAATAGTAGTAACCCCACAACATCAAATTCTGCCCCAGCA
TTAGATGCTGCAGAAACAGGGCACACTAGTAGTGTTCAACCAGAGGATGTCATTGAAACT
AGGTATGTGCAGACATCACAAACAAGAGATGAAATGAGTTTAGAGAGTTTTCTTGGCAGA
TCAGGATGCATACATGAATCTAAATTAGAGGTTACACTTGCAAATTATAACAAGGAGAAT
TTTACAGTGTGGGCTATTAATCTACAAGAAATGGCTCAAATTAGAAGGAAATTTGAATTG
TTCACCTATACTAGGTTTGATTCTGAAATAACCCTAGTTCCATGCATTTCCGCCCTTAGT
CAGGACATTGGACACATCACAATGCAATACATGTATGTTCCACCAGGTGCACCGGTGCCC
AATAGTAGGGACGATTATGCATGGCAGTCTGGCACTAATGCCTCTGTTTTCTGGCAACAT
GGACAGGCTTATCCAAGATTTTCCTTACCTTTCCTAAGTGTGGCATCTGCTTATTACATG
TTTTATGATGGGTATGATGAACAAGATCAAAACTATGGTACAGCAAACACAAATAACATG
GGGTCACTATGCTCTAGGATAGTAACAGAGAAACACATTCATAAAGTACATATAATGACA
AGAATCTATCACAAGGCTAAACATGTCAAGGCATGGTGTCCACGCCCACCCAGAGCGCTT
GAGTATACTCGTGCTCATCGCACTAATTTTAAAATTGAGGATAGGAGTATTCAGACAGCA
ATTGTGACCAGACCAATTATCACTACAGCTGGCCCCAGTGACATGTATGTTCATGTAGGT
AACCTTATTTATAGAAATCTTCATCTTTTCAACTCTGAGATGCATGAATCTATTTTGGTA
TCTTATTCATCAGATTTAATCATTTACCGAACAAACACTGTAGGTGATGATTACATTCCC
TCTTGTGATTGTACCCAAGCTACTTATTATTGCAAACATAAAAATAGATACTTCCCAATT
ACAGTTACAAGCCATGACTGGTATGAAATACAGGAAAGTGAGTACTATCCCAAACACATA
CAGTACAATTTGTTGATTGGTGAGGGCCCTTGTGAACCAGGTGACTGTGGTGGAAAGTTG
CTATGCAAACATGGTGTCATAGGTATAGTAACAGCTGGTGGTGATAATCATGTGGCTTTT
ATTGACCTTAGACACTTCCATTGTGCTGAAGAACAAGGGGTTACAGATTATATACATATG
CTAGGAGAAGCATTTGGAAATGGATTTGTGGATAGTGTAAAAGAACATATACATGCCATA
AACCCAGTAGGAAATATCAGCAAGAAAATTATTAAATGGATGTTGAGAATAATATCAGCA
ATGGTCATAATAATTAGAAACTCTTCTGACCCCCAAACTATATTAGCAACACTCACACTG
ATTGGGTGTTCTGGATCACCCTGGAGATTTTTAAAGGAAAAATTCTGTAAATGGACACAG
CTTAATTATATACACAAAGAATCAGATTCATGGTTAAAGAAATTTACTGAAGCATGCAAT
GCAGCTAGAGGGCTTGAATGGATAGGGAATAAGATATCTAAATTTATTGAATGGATGAAG
TCGATGCTCCCGCAAGCTCAATTGAAGGTTAAGTACTTAAACGAGCTTAAAAAACTCAAC
CTATACGAAAAGCAAGTTGAGAGCTTGCGGGTGGCTGACATGAAAACACAAGAAAAAATT
AAAATGGAAATAGACACTTTACATGATTTGTCACGTAAATTTCTACCTTTGTATGCAAGT
GAGGCAAAAAGGATAAAAACCCTATACATTAAATGTGATAATATCATCAAGCAGAAGAAA
AGATGTGAACCAGTAGCTATAGTTATTCATGGACCACCTGGTGCTGGCAAATCTATAACA
ACAAATTTCCTGGCCAAAATGATAACTAATGATAGTGACATATACTCTCTACCTCCTGAT
CCAAAATATTTTGATGGTTATGACCAACAGAGTGTAGTAATAATGGATGACATTATGCAG
AATCCAGCCGGGGATGACATGACACTGTTCTGCCAAATGGTTTCTAGTGTTACATTTATA
CCACCAATGGCTGATCTACCAGATAAAGGCAAGGCTTTTGATTCTAGGTTTGTATTATGC
AGCACAAATCATTCCCTTCTAACACCCCCGACAATAACTTCACTACCTGCAATGAATAGA
AGATTTTTCCTAGATTTAGATATAATAGTACATGATAACTTCAAAGATCCACAGGGCAAA
CTTAATGTGGCAGCAGCGTTTCGACCATGTGATGTAGATAATAGAATAGGAAATGCACGT
TGTTGTCCATTTGTGTGTGGAAAAGCAGTTTCTTTCAAAGATCGTAACTCTTGCAACAAA
TACAGCCTTGCGCAGGTGTACAACATAATGATTGAAGAAGACAGACGGAGAAGACAAGTG
GTTGATGTCATGACAGCTATATTCCAAGGGCCAATTGATATGAAAAACCCACCACCACCT
GCTATTACTGACTTGCTCCAGTCTGTTAGAACCCCTGAAGTTATTAAGTATTGTGAGGGT
AATAGATGGATAATTCCAGCAGAATGCAAGATAGAAAAGGAGTTGAACTTGGCTAACACA
ATCATAACAATCATTGCAAATGTTATTGGTATGGCGAGAATAATATATGTTATTTACAAA
CTTTTTTGCACATTACAGGGACCATATTCAGGAGAACCAAAGCCCAAGACTAAAATCCCA
GAAAGGCGTGTAGTAACACAGGGACCAGAGGAGGAATTTGGGATGTCTTTAATTAAACAT
AACTCATGTGTTATTACAACAGAAAATGGGAAATTCACAGGTCTTGGAGTATACGACAGA
TTTGTGGTCGTACCAACACATGCAGATCCTGGAAAGGAAATTCAGGTTGATGGTATAACT
ACAAAAGTCATTGACTCATATGACCTATACAACAAGAATGGGATAAAGCTAGAAATAACA
GTACTTAAATTAGATAGAAATGAAAAATTTAGAGATATCAGGAGATATATACCTAACAAT
GAAGATGATTACCCCAATTGCAACTTAGCACTGCTAGCAAACCAGCCTGAACCAACTATA
ATCAATGTTGGAGATGTTGTATCCTATGGCAATATACTGCTCAGTGGCAACCAAACGGCT
AGAATGCTTAAATACAGTTACCCAACTAAATCTGGTTACTGTGGAGGTGTCTTATACAAA
ATTGGGCAAGTGCTTGGAATACATGTTGGGGGCAATGGTAGGGATGGTTTCTCAGCTATG
TTACTCAGATCCTATTTCACTGATGTTCAGGGCCAAATAACGTTATCAAAGAAGACCAGT
GAATGTAACCTACCCAGTATACACACCCCATGCAAAACCAAATTGCAGCCTAGTGTTTTC
TATGATGTATTCCCTGGTTCAAAAGAACCAGCTGTGTTGTCTGAAAAAGATGCCCGGTTA
CAAGTTGATTTCAATGAAGCACTATTTTCTAAATACAAAGGGAATACAGATTGCTCCATT
AATGACCACATAAGAATTGCATCATCACATTATGCAGCACAACTCATTACCTTAGATATT
GACCCAAAACCTATTACACTTGAGGACAGTGTCTTTGGCACTGATGGATTAGAGGCTCTT
GATTTGAACACTAGCGCAGGATTTCCATATATTGCAATGGGAGTTAAAAAGAGAGATTTA
ATAAACAACAAGACCAAGGATATAAGCAAACTTAAAGAAGCAATTGACAAATACGGAGTT
GACTTACCTATGGTCACCTTCTTGAAAGATGAACTCAGAAAGCATGAAAAGGTAATTAAA
GGTAAAACTAGAGTTATTGAAGCTAGTAGTGTGAATGATACCCTATTATTTAGAACAACT
TTTGGCAACCTCTTTTCAAAGTTCCACTTGAATCCTGGAATTGTTACTGGATCAGCAGTT
GGATGTGATCCAGAGGTGTTTTGGTCAAAAATACCAGCAATGTTGGATGATAAATGTATT
ATGGCTTTTGATTATACAAATTATGATGGTAGTATACACCCTATTTGGTTTGAAGCTCTT
AAACAGGTACTGGTAGATCTATCATTTAATCCAACATTAATAGATAGACTATGCAAGTCT
AAACACATCTTCAAAAATACATACTATGAAGTGGAGGGAGGTGTACCATCTGGGTGTTCA
GGTACTAGTATTTTTAACACTATGATCAATAATATTATCATAAGGACCTTAGTGTTAGAT
GCATACAAGAATATAGATCTAGATAAGCTTAAGATAATTGCCTATGGTGATGATGTCATA
TTCTCATACATACATGAACTGGACATGGAGGCTATAGCAATAGAGGGTGTTAAATATGGT
TTGACTATAACTCCTGCTGATAAATCTAACACATTTGTAAAATTAGACTATAGCAATGTT
ACTTTTTTAAAAAGAGGGTTTAAGCAAGATGAGAAGTATAACTTTCTAATACATCCAACT
TTCCCTGAAGATGAAATATTTGAATCCATCAGATGGACAAAGAAACCATCACAAATGCAT
GAACATGTGTTGTCTCTGTGTCACTTAATGTGGCACAATGGACGTGACGCATACAAAAAA
TTTGTGGAGAAGATACGCAGTGTAAGCGCTGGTCGTGCACTGTACATCCCTCCGTATGAT
TTGCTTTTGCATGAGTGGTATGAAAAATTTTAA

# Drug_Target_1_General_Function:
Involved in nucleotide binding

# Drug_Target_1_General_References:
2987843	Skern T, Sommergruber W, Blaas D, Gruendler P, Fraundorfer F, Pieler C, Fogy I, Kuechler E: Human rhinovirus 2: complete nucleotide sequence and proteolytic processing signals in the capsid protein region. Nucleic Acids Res. 1985 Mar 25;13(6):2111-26.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2719

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
241980

# Drug_Target_1_Name:
Genome polyprotein

# Drug_Target_1_Number_of_Residues:
2150

# Drug_Target_1_PDB_ID:
Not Available

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00073	Rhv
PF00548	Peptidase_C3
PF00680	RdRP_1
PF00910	RNA_helicase
PF00947	Pico_P2A
PF01552	Pico_P2B
PF02226	Pico_P1A
PF08727	P3A

# Drug_Target_1_Protein_Sequence:
>Genome polyprotein [Contains: Capsid protein VP4
MGAQVSRQNVGTHSTQNSVSNGSSLNYFNINYFKDAASNGASKLEFTQDPSKFTDPVKDV
LEKGIPTLQSPTVEACGYSDRIIQITRGDSTITSQDVANAIVAYGVWPHYLSSKDASAID
KPSQPDTSSNRFYTLRSVTWSSSSKGWWWKLPDALKDMGIFGENMFYHYLGRSGYTIHVQ
CNASKFHQGTLIVALIPEHQIASALHGNVNVGYNYTHPGETGREVKAETRLNPDLQPTEE
YWLNFDGTLLGNITIFPHQFINLRSNNSATIIAPYVNAVPMDSMRSHNNWSLVIIPICPL
ETSSAINTIPITISISPMCAEFSGARAKRQGLPVFITPGSGQFLTTDDFQSPCALPWYHP
TKEISIPGEVKNLVEICQVDSLVPINNTDTYINSENMYSVVLQSSINAPDKIFSIRTDVA
SQPLATTLIGEISSYFTHWTGSLRFSFMFCGTANTTVKLLLAYTPPGIAEPTTRKDAMLG
THVIWDVGLQSTISMVVPWISASHYRNTSPGRSTSGYITCWYQTRLVIPPQTPPTARLLC
FVSGCKDFCLRMARDTNLHLQSGAIAQNPVENYIDEVLNEVLVVPNINSSNPTTSNSAPA
LDAAETGHTSSVQPEDVIETRYVQTSQTRDEMSLESFLGRSGCIHESKLEVTLANYNKEN
FTVWAINLQEMAQIRRKFELFTYTRFDSEITLVPCISALSQDIGHITMQYMYVPPGAPVP
NSRDDYAWQSGTNASVFWQHGQAYPRFSLPFLSVASAYYMFYDGYDEQDQNYGTANTNNM
GSLCSRIVTEKHIHKVHIMTRIYHKAKHVKAWCPRPPRALEYTRAHRTNFKIEDRSIQTA
IVTRPIITTAGPSDMYVHVGNLIYRNLHLFNSEMHESILVSYSSDLIIYRTNTVGDDYIP
SCDCTQATYYCKHKNRYFPITVTSHDWYEIQESEYYPKHIQYNLLIGEGPCEPGDCGGKL
LCKHGVIGIVTAGGDNHVAFIDLRHFHCAEEQGVTDYIHMLGEAFGNGFVDSVKEHIHAI
NPVGNISKKIIKWMLRIISAMVIIIRNSSDPQTILATLTLIGCSGSPWRFLKEKFCKWTQ
LNYIHKESDSWLKKFTEACNAARGLEWIGNKISKFIEWMKSMLPQAQLKVKYLNELKKLN
LYEKQVESLRVADMKTQEKIKMEIDTLHDLSRKFLPLYASEAKRIKTLYIKCDNIIKQKK
RCEPVAIVIHGPPGAGKSITTNFLAKMITNDSDIYSLPPDPKYFDGYDQQSVVIMDDIMQ
NPAGDDMTLFCQMVSSVTFIPPMADLPDKGKAFDSRFVLCSTNHSLLTPPTITSLPAMNR
RFFLDLDIIVHDNFKDPQGKLNVAAAFRPCDVDNRIGNARCCPFVCGKAVSFKDRNSCNK
YSLAQVYNIMIEEDRRRRQVVDVMTAIFQGPIDMKNPPPPAITDLLQSVRTPEVIKYCEG
NRWIIPAECKIEKELNLANTIITIIANVIGMARIIYVIYKLFCTLQGPYSGEPKPKTKIP
ERRVVTQGPEEEFGMSLIKHNSCVITTENGKFTGLGVYDRFVVVPTHADPGKEIQVDGIT
TKVIDSYDLYNKNGIKLEITVLKLDRNEKFRDIRRYIPNNEDDYPNCNLALLANQPEPTI
INVGDVVSYGNILLSGNQTARMLKYSYPTKSGYCGGVLYKIGQVLGIHVGGNGRDGFSAM
LLRSYFTDVQGQITLSKKTSECNLPSIHTPCKTKLQPSVFYDVFPGSKEPAVLSEKDARL
QVDFNEALFSKYKGNTDCSINDHIRIASSHYAAQLITLDIDPKPITLEDSVFGTDGLEAL
DLNTSAGFPYIAMGVKKRDLINNKTKDISKLKEAIDKYGVDLPMVTFLKDELRKHEKVIK
GKTRVIEASSVNDTLLFRTTFGNLFSKFHLNPGIVTGSAVGCDPEVFWSKIPAMLDDKCI
MAFDYTNYDGSIHPIWFEALKQVLVDLSFNPTLIDRLCKSKHIFKNTYYEVEGGVPSGCS
GTSIFNTMINNIIIRTLVLDAYKNIDLDKLKIIAYGDDVIFSYIHELDMEAIAIEGVKYG
LTITPADKSNTFVKLDYSNVTFLKRGFKQDEKYNFLIHPTFPEDEIFESIRWTKKPSQMH
EHVLSLCHLMWHNGRDAYKKFVEKIRSVSAGRALYIPPYDLLLHEWYEKF

# Drug_Target_1_Reaction:
nucleoside triphosphate + RNAn = diphosphate + RNAn+1

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
RNA-directed RNA polymerase replicates genomic and antigenomic RNA by recognizing replications specific signals

# Drug_Target_1_SwissProt_ID:
P04936

# Drug_Target_1_SwissProt_Name:
POLG_HRV2

# Drug_Target_1_Synonyms:
Capsid protein VP1
Capsid protein VP2
Capsid protein VP3
Core protein P2A
Core protein P2B
Core protein P2C
Core protein P3A
EC 2.7.7.48
EC 3.4.22.28
EC 3.4.22.29
Genome polyprotein [Contains: Capsid protein VP4
Genome-linked protein VPg
P1A
P1B
P1C
P1D
P3B
P3C
P3D]
Picornain 2A
Picornain 3C
Protease 3C
RNA-directed RNA polymerase
Virion protein 1
Virion protein 2
Virion protein 3
Virion protein 4

# Drug_Target_1_Theoretical_pI:
7.23

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB02313
